26.84
-0.08 (-0.30%)
| 前收盘价格 | 26.92 |
| 收盘价格 | 27.21 |
| 成交量 | 1,083,926 |
| 平均成交量 (3个月) | 1,132,121 |
| 市值 | 2,359,368,192 |
| 预期市盈率 (P/E Forward) | 4.65 |
| 价格/销量 (P/S) | 340.46 |
| 股市价格/股市净资产 (P/B) | 2.48 |
| 52周波幅 | |
| 利润日期 | 4 Nov 2025 |
| 营业利益率 (TTM) | -5,147.81% |
| 稀释每股收益 (EPS TTM) | -3.65 |
| 季度收入增长率 (YOY) | 78.50% |
| 总债务/股东权益 (D/E MRQ) | 2.54% |
| 流动比率 (MRQ) | 13.92 |
| 营业现金流 (OCF TTM) | -264.11 M |
| 杠杆自由现金流 (LFCF TTM) | -164.58 M |
| 资产报酬率 (ROA TTM) | -21.84% |
| 股东权益报酬率 (ROE TTM) | -31.34% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 混合的 | 混合的 |
| Biotechnology (全球的) | 混合的 | 混合的 | |
| 股票 | IDEAYA Biosciences, Inc. | 看跌 | 看跌 |
AIStockmoo 评分
| 分析师共识 | 2.0 |
| 内部交易活动 | NA |
| 价格波动 | 2.0 |
| 技术平均移动指标 | 0.0 |
| 技术振荡指标 | 0.5 |
| 平均 | 1.13 |
|
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Core |
| 内部持股比例 | 0.90% |
| 机构持股比例 | 117.09% |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 74.00 (JP Morgan, 175.71%) | 购买 |
| 中 | 45.00 (67.66%) | |
| 低 | 38.00 (RBC Capital, 41.58%) | 购买 |
| 平均值 | 48.00 (78.84%) | |
| 总计 | 7 购买 | |
| 平均价格@调整类型 | 25.04 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| Guggenheim | 18 Sep 2025 | 50.00 (86.29%) | 购买 | 26.22 |
| Mizuho | 12 Sep 2025 | 44.00 (63.93%) | 购买 | 24.61 |
| RBC Capital | 09 Sep 2025 | 38.00 (41.58%) | 购买 | 24.74 |
| Stephens & Co. | 09 Sep 2025 | 45.00 (67.66%) | 购买 | 24.74 |
| JMP Securities | 08 Sep 2025 | 45.00 (67.66%) | 购买 | 23.39 |
| 04 Sep 2025 | 41.00 (52.76%) | 购买 | 25.83 | |
| Barclays | 04 Sep 2025 | 40.00 (49.03%) | 购买 | 25.83 |
| JP Morgan | 03 Sep 2025 | 74.00 (175.71%) | 购买 | 25.76 |
| 28 Jul 2025 | 72.00 (168.26%) | 购买 | 25.02 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合